Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors-Reference-Cited by-同舟云学术

Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors

Published:2016-05-01 Issue:5 Volume:2 Page:608
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Harris Marian H.¹,DuBois Steven G.²,Glade Bender Julia L.³,Kim AeRang⁴,Crompton Brian D.⁵,Parker Erin⁵,Dumont Ian P.⁵,Hong Andrew L.⁵,Guo Dongjing⁵,Church Alanna¹,Stegmaier Kimberly⁵⁶,Roberts Charles W. M.⁵⁶,Shusterman Suzanne⁵⁶,London Wendy B.⁵⁶,MacConaill Laura E.⁷⁸,Lindeman Neal I.⁶⁸,Diller Lisa⁵⁶,Rodriguez-Galindo Carlos⁵⁶,Janeway Katherine A.⁵⁶

Affiliation:

1. Department of Pathology, Boston Children’s Hospital, Boston, Massachusetts

2. Division of Pediatric Hematology Oncology, University of California–San Francisco Benioff Children’s Hospital

3. Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, NewYork–Presbyterian Morgan Stanley Children’s Hospital, New York

4. Center for Cancer and Blood Disorders, Children’s National Medical Center, Washington, DC

5. Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, Massachusetts

6. Harvard Medical School, Boston, Massachusetts

7. Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts

8. Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2484355/jamaoncology_harris_2016_oi_150108_1610725324.05315.pdf

Reference17 articles.

1. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.;Romond;N Engl J Med,2005

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.;Paez;Science,2004

3. Cancer genome landscapes.;Vogelstein;Science,2013

4. Prospective enterprise-level molecular genotyping of a cohort of cancer patients.;MacConaill;J Mol Diagn,2014

5. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.;Wagle;Cancer Discov,2012

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision oncology across the ages: Impact on children, adolescents, and young adults;Cancer Cell;2024-09

2. Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer;Nature Communications;2024-07-11

3. Recent Advancements and Innovations in Pediatric Precision Oncology;Journal of Pediatric Hematology/Oncology;2024-06-10

4. Precision-guided treatment in high-risk pediatric cancers;Nature Medicine;2024-06-06

5. Molecular Alterations in Pediatric Solid Tumors;Clinics in Laboratory Medicine;2024-06